Forbius competitorsClear all
Forbius's top competitors include Agios Pharmaceuticals, CytomX Therapeutics and Bolt Biotherapeutics.
 Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | |
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 2008 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Austin, US HQ Montréal, CA | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | Locations Redwood City, US HQ |
Employees | Employees 1313% decrease | Employees 53611% increase | Employees 15815% increase | Employees 63 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 105.7 m | Valuation ($) 60.8 m |
Twitter followers | Twitter followers 98 | Twitter followers 2.4 k | Twitter followers 970 | Twitter followers 242 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 21 | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 2 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 6.5 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 617754 | Alexa Website Rank 524109 | Alexa Website Rank 634424 |
Employee Rating | Employee Rating 2.8 | Employee Rating N/A | Employee Rating 3.5 | Employee Rating 5 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $203.2m (FY, 2020) | Revenue (est.) $100.4m (FY, 2020) | Revenue (est.) $215k (FY, 2019) |
Net income | Net income N/A | Net income ($327.4m) (FY, 2020) | Net income ($32.9m) (FY, 2020) | Net income ($30.5m) (FY, 2019) |
Operating ⚠ | ||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 13 (FY, 2016) | Patents (US) 1 (FY, 2020) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 132.4m | Total funding raised $ 177.5m |
For sources of this data, please see the company profile
View company profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyCytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companyBolt Biotherapeutics
HQ
Redwood City, US
Employees
63
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company